Tuesday, November 24, 03:46 am IST
Hot Searches:  mukesh ambanisugarforbes rich list
| Feedback
Moneycontrol » News Center » Business » Business
Sun Pharma announces approval to mkt Razadyne tm Tablets
Published on Thu, Aug 30, 2007 at 18:40   |  Updated at Thu, Aug 30, 2007 at 19:11  |  Source : Moneycontrol.com

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the company’s Abbreviated New Drug Application (ANDA) for generic Razadyne tm, galantamine tablets.

 


Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer’s type.

 

These generic versions of galantamine are bio-equivalent to Razadyne tm distributed by Ortho-McNeil Neurologics, Inc. The ANDA includes three strengths: tablets containing galantamine hydrobromide equivalent to 4mg, 8 mg and 12 mg base.

 

These strengths of branded galantamine have annual sales of approximately USD 120 million in the US.

 

Razadyne tm is a trademark of Johnson & Johnson. 

 

Sourced from: Sun Pharmaceutical Industries Ltd

 

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
©Network 18, 2009. All Rights Reserved